TG Therapeutics
TGTX
#3008
Rank
โ‚น478.15 B
Marketcap
โ‚น2,994
Share price
-0.72%
Change (1 day)
-12.18%
Change (1 year)

Revenue for TG Therapeutics (TGTX)

Revenue in 2025 (TTM): โ‚น54.08 Billion

According to TG Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น58.12 Billion. an increase over the revenue in the year 2024 that were of โ‚น28.22 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for TG Therapeutics from 1996 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น55.32 B96.02%
2024 โ‚น28.22 B45.09%
2023 โ‚น19.45 B8343.66%
2022 โ‚น0.23 B-53.73%
2021 โ‚น0.49 B4378.71%
2020 โ‚น11.11 M2.56%
2019 โ‚น10.83 M1.99%
2018 โ‚น10.62 M9.44%
2017 โ‚น9.71 M-6.22%
2016 โ‚น10.35 M2.26%
2015 โ‚น10.12 M4.86%
2014 โ‚น9.65 M2.59%
2013 โ‚น9.41 M802.65%
2012 โ‚น1.04 M
2011 N/A
2010 N/A
2009 N/A
2000 โ‚น0.25 B379.44%
1999 โ‚น52.16 M-61.66%
1998 โ‚น0.13 B1054.06%
1997 โ‚น11.78 M9.32%
1996 โ‚น10.78 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Alkermes
ALKS
โ‚น139.19 B 139.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Dr. Reddy's Laboratories
RDY
โ‚น373.03 B 541.81%๐Ÿ‡ฎ๐Ÿ‡ณ India